Bio Medica LaboratoriesNSE:BMLL +0.49%14 Days Payable is 56.75 as of Mar. 2025, which is 58% below its 10-year median of 135.37. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Bio Medica Laboratories ranks worse than 61.51% on this metric.
The historical rank and industry rank for Bio Medica Laboratories's Days Payable or its related term are showing as below:
NSE:BMLL'
s Days Payable Range Over the Past 10 Years
Min: 56.75 Med: 135.37 Max: 157.23
Current: 56.75
During the past 3 years, Bio Medica Laboratories's highest Days Payable was 157.23. The lowest was 56.75. And the median was 135.37.
NSE:BMLL's Days Payable is ranked worse than 61.51% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs NSE:BMLL: 56.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Medica Laboratories Days Payable Chart
Bio Medica Laboratories Annual Data
Trend
Mar23
Mar24
Mar25
Days Payable
135.37
157.23
56.75
Bio Medica Laboratories Semi-Annual Data
Mar23
Mar24
Mar25
Days Payable
135.37
157.23
56.75
NSE:BMLL vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Bio Medica Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Medica Laboratories Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio Medica Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where Bio Medica Laboratories's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bio Medica Laboratories's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Medica Laboratories (NSE:BMLL) has a Days Payable of 56.75 as of Mar. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bio Medica Laboratories and its competitors. This is 58% below median its historical median of 135.37. Over the past decade, Bio Medica Laboratories' Days Payable has ranged from 56.75 to 157.23. According to the industry distribution chart, Bio Medica Laboratories ranks #489 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 61.5%.
Is Bio Medica Laboratories' Days Payable too high?
Bio Medica Laboratories' current Days Payable of 56.75 is 58% below median its 10-year median of 135.37. Over the past 10 years, this metric has ranged from a low of 56.75 to a high of 157.23. The Medical Devices & Instruments industry median Days Payable is 68.07. Bio Medica Laboratories' value of 56.75 is 16.6% below this industry median. Based on the distribution chart, Bio Medica Laboratories ranks #489 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bio Medica Laboratories ranks #489 out of 795 companies for Days Payable. This places Bio Medica Laboratories in the lower half of its industry. The industry median Days Payable is 68.07. Bio Medica Laboratories' value of 56.75 is 16.6% below this benchmark. Historically, Bio Medica Laboratories' own Days Payable has ranged from 56.75 to 157.23 over the past decade. While the company's 10-year median is 135.37 vs. the industry median of 68.07, Bio Medica Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Medica Laboratories's current Days Payable of 56.75 is 16.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bio Medica Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Medica Laboratories's current Days Payable is 56.75, which is 58% below median its own 10-year median of 135.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Days Payable of 56.75. The current Days Payable is 56.75, which is 58% below median its 10-year median of 135.37 and 16.6% below the Medical Devices & Instruments industry median of 68.07. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Days Payable is 56.75 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score
Get the complete analysis for NSE:BMLL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BMLL has been successfully added to your 